Ketamine found to be safe, effective for chronic pain
Low-dose IV infusions of ketamine are safe and effective in treating chronic pain, a new study says.
Oct 10, 2025
0
26
MeSH tree: D12.776.543.750.720.200
Low-dose IV infusions of ketamine are safe and effective in treating chronic pain, a new study says.
Oct 10, 2025
0
26
Could a simple blood test reveal how well someone is aging? A team of researchers led by Wolfram Weckwerth from the University of Vienna, Austria, and Nankai University, China, has combined advanced metabolomics with cutting-edge ...
Sep 29, 2025
0
50
When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, know ...
Sep 24, 2025
0
58
The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor ...
Sep 1, 2025
0
47
Schizophrenia is a serious mental health condition that affects thoughts, moods, perceptions, and behaviors. Affected individuals experience positive symptoms like delusions and hallucinations, and negative symptoms like ...
Jul 24, 2025
0
12
A research team has identified a molecular mechanism that coordinates the operation of the N-methyl-D-aspartate (NMDA) glutamate receptor, which is key to regulating excitatory synapse function in the brain. This achievement ...
May 19, 2025
0
25
A research team has unveiled the cause and molecular mechanism of chronic brain inflammation that results in repetitive behavioral disorders. The research team demonstrated that an inflammatory response by immune cells in ...
May 19, 2025
0
107
Our brain requires a constant supply of energy. A disrupted energy supply, as, for instance, caused by a stroke, can have serious complications. A team from the research group Cellular Neurobiology at Ruhr University Bochum, ...
Apr 22, 2025
0
21
Although a plethora of medications and therapies now exist for major depression, roughly one in three diagnosed patients still suffer from treatment-resistant depression (TRD)—a form of the disorder that does not respond ...
Apr 3, 2025
0
99
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused ...
Feb 20, 2025
0
16